Showing results (111-120 of 1,070) with videos related to

Sort By:
Pageof 107
Therapeutic Advances in Neurological Disorders|August 4, 2025
Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brainTanja Sjöros, Maija Saraste, Markus Matilainen, et al.
Therapeutic Advances in Neurological Disorders|March 27, 2025
Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravisYufan Zhou, Qian Zhou, Yaoxian Yue, et al.
Therapeutic Advances in Neurological Disorders|September 3, 2013
Targeting ion channels for the treatment of autoimmune neuroinflammationStefan Bittner, Sven G Meuth
Therapeutic Advances in Neurological Disorders|March 14, 2013
Recent advances in the management of choreasJean-Marc Burgunder
Therapeutic Advances in Neurological Disorders|March 14, 2013
Recent advances in the treatment of familial amyloid polyneuropathyDavid Adams
Therapeutic Advances in Neurological Disorders|May 2, 2013
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challengesKlaus Lehmann-Horn, Helena C Kronsbein, Martin S Weber
Therapeutic Advances in Neurological Disorders|May 2, 2013
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case reportAnke Stroet, Nadine Trampe, Andrew Chan
Therapeutic Advances in Neurological Disorders|November 15, 2013
The role of neuroimaging in the diagnosis of headache disordersDagny Holle, Mark Obermann
Therapeutic Advances in Neurological Disorders|November 25, 2015
An update on the management of post-traumatic headacheMark Obermann, Steffen Naegel, Bert Bosche, et al.
Therapeutic Advances in Neurological Disorders|September 2, 2017
Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in ChinaLei Zhou, Weibin Liu, Wei Li, et al.
Pageof 107